Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta‐analysis

Vancampfort, Davy, Correll, Christoph U., Galling, Britta, Probst, Michel, De Hert, Marc, Ward, Philip B., Rosenbaum, Simon, Gaughran, Fiona +2 more·2016·World Psychiatry

Cited by (660)

Items 601–660 of 660

  1. Search for surrogate markers to predict end stage kidney disease in long term lithium users
    Merel J. van der Aa, Anna A. Bonenkamp, Ursula M. H. Klumpers, Ralph Kupka, Tom Nijenhuis, Angèle P. M. Kerckhoffs · 2025 · International Journal of Bipolar Disorders
  2. Severe Mental Disorders and Cardiovascular Diseases
    Martina Rojnić Kuzman, Sara Medved · 2025 · Springer eBooks
  3. Managing co-occurring physical disorders in mental health care
    Delia Cimpean Hendrick, Robert E. Drake · 2025 · Oxford University Press eBooks
  4. Genotype-Epigenome-Phenotype Integration Reveals the Contributions of Peripheral Immune Cells to Bipolar Disorder Pathogenesis, Phenotypic Heterogeneity, and Therapy
    Lei Hou, Yue Li, Xushen Xiong, Yosuke Tanigawa, Yongjin Park, Samuel W. Lenz, Amy Grayson, Jeong‐Heon Lee, Euijung Ryu, Janet E. Olson et al. · 2025 · medRxiv
  5. Lifestyle in Mental and Physical Disorders
    Shuichi Suetani, Wolfgang Marx, Dan J. Siskind · 2025 · Springer eBooks
  6. Health Care Use, Care Settings, and Location of Death for People With Schizophrenia in Long-Term Care
    Katie Dover, Jess G. Fiedorowicz, David H. Kirkwood, Marco Solmi, James M. Bolton, Sarina Roslyn Isenberg, Wenshan Li, Alyson L Mahar, Shirley Harvey Bush, Michael J. Bonares et al. · 2025 · Journal of the American Medical Directors Association
  7. Psychiatric morbidity among medical clinic attendees at a tertiary care hospital in Sri Lanka during the economic crisis
    Shamila De Silva, Dileepa Senajith Ediriweera, Aruni Hapangama · 2026 · Scientific Reports
  8. Physical health among persons with untreated psychotic disorder in diverse settings of the Global South
    Akin Ojagbemi, Olufemi Idowu, Bola Olley, Georgina Miguel Esponda, Tessa Roberts, Sujit John, Vijaya Raghavan, Joni Lee Pow, Casswina Donald, Olatunde Olayinka Ayinde et al. · 2025 · Schizophrenia Research
  9. Associations of migrant and refugee status with physical comorbidity and mortality among young adults with incident non-affective psychotic disorders
    Alexis E. Cullen, Christopher Jamil de Montgomery, Emma Pettersson, Aemal Akhtar, Marie Louise Nørredam, Heidi T. Taipale, Ellenor Mittendorfer‐Rutz · 2025 · BMC Public Health
  10. The role of physical activity in the bidirectional association between depressive symptoms and chronic disease incidence: A prospective analysis of the Irish longitudinal study on ageing
    André O. Werneck, Felipe Barreto Schuch, Davy Vancampfort, Liye Zou, José Francisco López‐Gil, Joseph Firth, Nicola Veronese, Nilufar Mossaheb, Brendon Stubbs · 2025 · Journal of Psychosomatic Research
  11. Diabetes mellitus and associated factors among psychiatric patients receiving antipsychotic treatment at Wachemo University Nigist Elleni Hospital, South Ethiopia
    Amanuel Melaku Laemango, Misgana Bekele Begna, Dembelo Tirago Masebo, Dilebo Lefebo Anshebo, S Woyesa, Mengistu Lodebo Funga · 2025 · PLoS ONE
  12. Polygenic risks and cardiovascular treatment effects in severe mental illness
    Kai Yao, Alexandra Burton, Samira Heinkel, David Osborn, Nicholas James Bass, Andrew McQuillin · 2025 · Psychiatric Genetics
  13. Prevalence and Risk Factors of Comorbid Type 2 Diabetes Mellitus in Adults With Severe Mental Disorders: A Retrospective Study
    Jiao Hu, Xida Wang, X Huang, Zhuozhuo Cheng, Huiling Ye, Haofeng Xu, Youping Wang · 2025 · ALPHA PSYCHIATRY
  14. Prescribing of glucose‐lowering medication to adults with type 2 diabetes by severe mental illness status in Scotland: A cohort study
    Jilly Adams, Shuvajit Saha, Kelly J. Fleetwood, Luke A. K. Blackbourn, Stuart J. McGurnaghan, Sarah H. Wild, Caroline Jackson · 2025 · Diabetes Obesity and Metabolism
  15. Additional file 1 of Temporally ordered associations between type 2 diabetes and brain disorders – a Danish register-based cohort study
    Theresa Wimberley, Henriette Thisted Horsdal, Isabell Brikell, Thomas Munk Laursen, Aske Astrup, Giuseppe Fanelli, Bralten, Janita, Geert Poelmans, Veerle van Gils, Willemijn J. Jansen et al. · 2022 · Figshare
  16. Additional file 1 of The impact of providing care for physical health in severe mental illness on informal carers: a qualitative study
    Dolly Sud, Eleanor Bradley, Jonathan Quetzal Tritter, Maidment, Ian · 2024 · Figshare
  17. Additional file 1 of Gender differences in depressive symptoms of rural Chinese grandparents caring for grandchildren
    Zhao, Dantong, Zhou, Zhongliang, Chi Shen, Sahardid Hussein Ibrahim, Yaxin Zhao, Dan Cao, Lai, Sha · 2021 · Figshare
  18. Additional file 1 of Incremental burden of comorbid major depressive disorder in patients with type 2 diabetes or cardiovascular disease: a retrospective claims analysis
    Anne Kangethe, Debra F. Eisenberg Lawrence, Maëlys Touya, Lambros Chrones, Polson, Michael, Themmi Evangelatos · 2021 · Figshare
  19. Hyperglycémies iatrogènes en dehors du virus de l’immunodéficience humaine
    P. Treca, C. Amouyal · 2025 · EMC - Endocrinologie - Nutrition
  20. Physical Exercise to Improve Negative Symptoms, Cognitive Deficits, and Levels of Daily-Life Functioning in Schizophrenia Spectrum Disorders: Current Evidence and Treatment Recommendations
    Lukas Roell, Isabel Maurus, Andrea Schmitt, Peter Falkai · 2025 · Comprehensive approach to psychiatry
  21. Managing health in dual diagnosis: narratives from individuals with schizophrenia and diabetes
    Matilde Zerne Nilsson, Carina Sparud-Lundin, Katarina Eeg‐Olofsson, Peter K. Sand, Christina Hagberg, Christopher Holmberg · 2026 · Frontiers in Psychiatry
  22. Sertraline for the Treatment of Major Depressive Disorder in the US: Effectiveness and Acceptability in Real-World Practice
    C. Correll, P. Purushottamahanti, K. Subramaniam, B. Bayan, J. Cook, E. O. Palmer, J. Yeow, N. Lipunova · 2026 · Neuropsychiatric Disease and Treatment
  23. Predictive Factors of Low HDL-C in Patients with Schizophrenia
    Yu-Chi Huang, Chi‐Fa Hung, Yu Lee, Pao‐Yen Lin, Liang‐Jen Wang · 2026 · Neuropsychiatric Disease and Treatment
  24. Identifying priority topics for interprofessional education on lifestyle interventions in mental healthcare: a modified Delphi study
    Oscar Lederman, Sam Manger, Linda Barron, Felice N. Jacka, Tetyana Rocks · 2026 · Critical Public Health
  25. Trends in bipolar disorder-related mortality in the United States, 1999–2023: A CDC WONDER database analysis
    Sowmya Kolluru, Mustafa Beidas, Olivia Anne Foley, Rajesh R. Tampi, Abubakar Tauseef · 2026 · International Journal of Bipolar Disorders
  26. Comparing perspectives of volunteers and patients on the Health Champions intervention in secondary mental healthcare: a qualitative study
    Mariana Pinto da Costa, Wen Ching Andrea Chang, Yuxin Wu, Scarlett Spence, Hyeon Ji Cho, Ray McGrath, Euan Sadler, Gracie Tredget, Isobel Mdudu, Fiona Gaughran et al. · 2026 · BMJ Open
  27. Impact of Adjuvant GLP-1RA Treatment on the Adherence of Second-Generation Antipsychotics in Nondiabetic Adults
    Jerusha Daggolu, Michael Okonkwo, H. Chen · 2026 · Journal of Clinical Psychopharmacology
  28. Decreased lithium levels associated with dapagliflozin in a patient with type 1 diabetes and bipolar disorder – a case report
    Andrzej Juryk, Patrycja Król, Maria Mroczka, Agnieszka Czernecka, Marcin Siwek, Dominika Dudek, Rafał Roman Jaeschke · 2026 · Psychiatria i Psychologia Kliniczna
  29. The interplay of multimorbidity and depressive symptoms: mediation role of functional dependence
    Rui She, Haiyue Luo, Shanquan Chen, Fangfei Xiong, Karen P. Y. Liu, Marco Y.C. Pang · 2026 · Epidemiology and Psychiatric Sciences
  30. Sodium-Glucose Cotransporter-2 Inhibitors in Mood Disorders: A Narrative Review of Mechanisms, Evidence, and Challenges
    Xiuqi Guo, Tao Yang, Yiru Fang, Jun Chen · 2026 · Neuropsychiatric Disease and Treatment
  31. Predicting stress-induced vulnerability to depression in diabetes
    Lynn M. Alaeddine · 2022
  32. Linking Brain, Hormones, and Metabolism: Pathophysiology and Treatment of Antipsychotic-Induced Cardiometabolic Side Effects
    Walter Milano, Roberta Campanile, Magda Marchese, Maria Francesca Milano, Ludovica Ragozino, Biancamaria Saetta, Anna Capasso · 2026 · OBM Neurobiology
  33. Patient and System Factors Associated with Second-generation Antipsychotic Metabolic Lab Monitoring, a Retrospective Cohort Study
    Sorabh Singhal, Susan K. Mikulich‐Gilbertson, Maria E. Garcia, Sarah M. Nagle-Yang, Allison G. Dempsey · 2026 · Community Mental Health Journal
  34. Non-pharmacological interventions for antipsychotic drug-related metabolic abnormalities: a systematic narrative review
    Jingfang Liu, Jingmin Song, Jinna Xie, Mei Ling, K eqin Li, Xuan Gong, Min Yang, Jing Wang · 2026 · BMC Psychiatry
  35. Managing metabolic syndrome in bipolar disorder: multidisciplinary monitoring and treatment strategies
    Jorge César Correia, Hélène Richard-Lepouriel, Anne Chalut-Carpentier, Zoltan Pataky · 2026 · Frontiers in Psychiatry
  36. Design, implementation and evaluation of PSY-KOMO care - Improving the quality of treatment for people with severe mental illness to reduce physical comorbidity and prevent increased mortality: a study protocol
    Anja Viehmann, Natalia Wege, Verena Leve, Frank Jacobi, Martina Hahn, Walter Hewer, Julia Katharina Wolff, David Schneider, Catharina Scholl, Stefan Wilm et al. · 2026 · Research Square
  37. Nature‐Based Physical Activity to Enhance Mental Health and Wellbeing: A Scoping Review to Identify Recommendations for Applied Practice
    Paul Sellars, Alexis Bennett, Diane Crone, Jenny Mercer, Debbie Clayton · 2026 · Mental Health Science
  38. Psychotropic medication use, lifestyle, genetic risk for high BMI and the incidence of cardiovascular disease
    Nini de Boer, Iris Hanskamp, Bochao Danae Lin, Liese Boonstra, Marte Z. van der Horst, Kristel R. van Eijk, Marco P. Boks, Wouter J. Peyrot, Jos W. R. Twisk, Thomas Goldschmidt et al. · 2026 · Nature Mental Health
  39. Depression and Its Association With Microvascular and Macrovascular Complications in Type 2 Diabetes
    Mariam Wehbi, Ahmad Al‐Bitar, Zaynab Alourfi, Younes Kabalan · 2026 · Journal of Diabetes Research
  40. Genotype epigenome phenotype integration reveals peripheral immune contributions to type I bipolar disorder
    Lei Hou, Yue Li, Xushen Xiong, Yosuke Tanigawa, Yongjin Park, Samuel W. Lenz, Amy Grayson, Jeong‐Heon Lee, Euijung Ryu, Janet E. Olson et al. · 2026 · Nature Communications
  41. Association between cardiometabolic index and mortality risk in patients with depression: A comprehensive analysis based on two national cohorts
    Yixuan Xie, Jiawang Jin, Ting Zhou · 2026 · Medicine
  42. Development of Physical Activity from Childhood to Adolescence in Offspring at Familial High Risk of Schizophrenia or Bipolar Disorder and Population-Based Controls: The Danish High Risk and Resilience Study
    Anne Søndergaard, Sinnika Birkehøj Rohd, Marta Schiavon, Doris Helena Bjarnadóttir Streymá, Martin Wilms, Maja Gregersen, Anette Faurskov Bundgaard, Andreas Færgemand Laursen, Nicoline Hemager, Mette Falkenberg Krantz et al. · 2026 · Schizophrenia Bulletin Open
  43. Lactate-Mediated Brain Acidosis Drives Epigenetic Dysregulation of TGFB2 and Associated Gene Networks in Schizophrenia and Bipolar Disorder
    Hamid M. Abdolmaleky, Shabnam Nohesara, Reshma Subramonian, Kodhai Duraiarasan, Melissa Dorzin, Jin‐Rong Zhou, Giuseppe Pettinato, Sam Thiagalingam · 2026 · International Journal of Molecular Sciences
  44. Monitoring physical health in child and adolescent mental health inpatient care: findings from the Y-Health longitudinal feasibility study
    Rebekah Carney, Shermin Imran, Heather Law, Karina Lovell, Rathi Ravindrarajah, Clare Fenton, Nicola Green, Gillian Macafee, Olorunleke Erunkulu, Sophie Parker · 2026 · Frontiers in Child and Adolescent Psychiatry
  45. Incidence patterns of cardiometabolic comorbidities in patients with schizophrenia: A retrospective cohort study in Korea
    Juyeon Lee, J.S. Kim, Jimin Hwang, Seonghae Kim, Sung Woo Joo, Bo Ram Yang · 2026 · Psychiatry Research
  46. Safety and Tolerability of Adjunctive Lumateperone for the Treatment of Major Depressive Disorder: A Pooled Analysis of Two Randomized Placebo-Controlled Trials
    Willie R. Earley, Suresh Durgam, Susan G Kozauer, Changzheng Chen, Raffaele Migliore, Christoph Ulrich Correll · 2026 · CNS Drugs
  47. Cancer-related mortality among individuals with schizophrenia: systematic review and meta-analysis of cohort studies
    Seyyed Muhammad Mahdi Mahdavinoor, Aghil Mollaei, Mohammad Hasan Golzar, Saeed Kargar-Soleimanabad, Amir‐Hassan Bordbari, Melika Amiri, Mohammad Hosein Rafiee, Leila Seddigh · 2026 · BJPsych Open
  48. Quality-of-life and self-perceived inequity in people with severe mental illness: the SOFIA pilot study
    Maarten Pieter Rozing, Volkert Siersma, Kristine Henderson Bissenbakker, Maria Haahr Nielsen, Alexandra Brandt Ryborg Jønsson, Anne Møller, John Brodersen · 2026 · Scandinavian Journal of Primary Health Care
  49. FOR-HEALTH: study protocol for a randomized controlled feasibility trial of Structured Health Dialogues to improve lifestyle habits and metabolic health in forensic psychiatric inpatients
    Mikael Vestlund, Veronica Milos Nymberg, Peter Andiné, Märta Wallinius · 2026 · Pilot and Feasibility Studies
  50. Long-term safety and tolerability of lumateperone 42 mg in patients with stable symptoms of schizophrenia: Results from a 1-year open-label study
    Christoph Ulrich Correll, Suresh Durgam, Susan G Kozauer, Changzheng Chen, Willie R. Earley · 2026 · Schizophrenia Research
  51. An exploratory retrospective analysis of concurrent metabolic and behavioral change in Prader-Willi syndrome during interdisciplinary inpatient stabilization
    Geethanjali Ravindranathan, Blythe Stockton, June Finnerty, Amanda Collier, John W. Cassidy · 2026 · Journal of Psychiatric Research
  52. From Insulin Resistance to Mitochondrial Failure: A Staged Model of Impaired Metabolic Flexibility in Schizophrenia
    Myles Cubitt, Bart A. Ellenbroek, Anne M. Haase · 2026 · Biomolecules
  53. Feasibility, Acceptability, and Preliminary Effectiveness of My AI Companion with Adults with Serious Mental Illness: A Single Arm Pre-Post Intervention Study (Preprint)
    Shamika Morales, Marshall David Bedder, Vedant N. Tapiavala, Dylan Edward Moore, Karen L. Fortuna · 2026
  54. Lithium Toxicity Following Initiation of Semaglutide in a Patient With Bipolar Disorder: A Case Report
    Annika Dhingra, Charissa M Nichols, Ezekiel Sanchez, Anurag Ayyagari, Yashvi Rateshwar, Nina Narvaez · 2026 · Cureus
  55. Metabolic syndrome in patients diagnosed with affective disorders: a cross-sectional study among inpatients from two Cluj-Napoca psychiatry clinics
    P. Huluba, Florin C. Lung, B. Crecan-Suciu, R. Păunescu, Anca C. Bibolar, I. Micluția · 2026 · Frontiers in Psychiatry
  56. Parental Cardiometabolic History, Family Income, and Cardiometabolic Risk in Antipsychotic-Treated Children, Adolescents, and Young Adults: A Nationwide Cohort Study
    Mikkel Højlund, Rikke Thaarup Wesselhoeft, Anne Katrine Pagsberg, Christoph Ulrich Correll, Hans‐Christoph Steinhausen · 2026 · CNS Drugs
  57. Ruhsal Bozukluğu Olan Bireylerde Fiziksel Sağlığın Korunması ve Hemşirelik Yaklaşımları
    Şeyda Memiş, Sema Köse · 2026 · Özgür Yayınları eBooks
  58. A critical review of the role of pharmacists in providing care to Indigenous peoples with diabetes mellitus
    Izuchukwu Ejie, Sidra Uzair, Katherine A.W. Hillier, Ginny L Lane, Jarron Yee, Hassan Vatanparast, Kerry D. Mansell · 2026 · International Journal of Pharmacy Practice
  59. Revisiting SAVA: Syndemic transition and the reconfiguration of disease and inequality
    Nicola L. Bulled, Noa Kantorovich · 2026 · Medical Anthropology Quarterly
  60. BindingDB Entry 50012271: Isoquinolinone derivatives as potent CNS multi-receptor D
    BindingDB · 2022 · UC San Diego